投影分辨光学相干断层扫描血管成像可视化糖尿病视网膜病变中3个不同视网膜丛
本病例对照研究纳入29例糖尿病视网膜病变(DR)患者(47眼)和15名健康对照(29眼),采用投影分辨(PR)光学相干断层扫描血管成像(OCTA)区分浅层、中间层和深层视网膜丛。PR-OCTA在全部眼中显示3个不同视网膜丛,盲法判读毛细血管无灌注检测DR的敏感度和特异度均为100%,高于未分割视网膜血管成像的敏感度78.7%和特异度100%,并可更准确区分重度与轻度DR。
要点
- PR-OCTA在全部受检眼中清晰显示3个不同视网膜丛。
- 3层PR-OCTA盲法判读检测DR的敏感度和特异度均为100%。
- PR-OCTA较常规OCTA更准确区分重度与轻度DR。
核心结论
- PR-OCTA通过清晰呈现3个视网膜血管丛,可显示深层毛细血管异常,并可能较常规OCTA更准确地区分DR与健康眼以及重度DR与轻度DR。
研究设计与样本
- 病例对照研究,2015年1月26日至2015年12月4日在一家三级学术中心纳入DR患者和健康对照,采用谱域70-kHz OCT获取3×3-mm黄斑扫描,PR算法抑制投影伪影,半自动分割算法将PR-OCTA分为浅层、中间层和深层视网膜丛,两名盲法判读者评估非灌注和异常毛细血管。
- 共纳入29例DR患者的47眼(平均[SD]年龄55.5[11.9]岁;10名女性)和15名健康个体的29眼(平均[SD]年龄36.2[13.4]岁;11名女性)。
主要发现
- PR-OCTA在全部眼中于已知解剖位置显示3个不同视网膜丛。
- 健康眼的中间层和深层丛显示密度和管径均匀的毛细血管网,而浅层丛显示熟悉的向心性分支模式。
- DR眼的3层PR-OCTA显示不一致的非灌注区域以及深层丛中管径和密度不一的血管。
- 3层PR-OCTA盲法判读毛细血管无灌注检测DR的敏感度为100%(95%CI,90.8%-100%),特异度为100%(95%CI,85.4%-100%)。
- 未分割视网膜血管成像的敏感度为78.7%(95%CI,63.9%-88.8%),特异度为100%(95%CI,85.4%-100%),敏感度比较P=.002。
关键数值与推荐
- 3层PR-OCTA上,对于2个或更多独立丛中存在广泛非灌注的重度非增殖性DR和增殖性DR眼,敏感度为72.2%(95%CI,54.6%-85.2%);而联合血管成像上,广泛非灌注的敏感度为25.0%(95%CI,12.7%-42.5%),P<.001。
- PR-OCTA在23眼(100%)增殖性DR、13眼(100%)重度非增殖性DR、8眼(73%)轻至中度非增殖性DR中显示中间层和深层丛血管扩张,对照眼为0眼。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Projection artifacts in optical coherence tomography angiography (OCTA) blur the retinal vascular plexuses together and limit visualization of the individual plexuses. OBJECTIVE: To describe projection-resolved (PR) OCTA in eyes with diabetic retinopathy (DR) and healthy eyes. DESIGN, SETTING, AND PARTICIPANTS: In this case-control study, patients with DR and healthy controls were enrolled in this observational study from January 26, 2015, to December 4, 2015, at a tertiary academic center. Spectral-domain, 70-kHz OCT obtained 3 × 3-mm macular scans. The PR algorithm suppressed projection artifacts. A semiautomated segmentation algorithm divided PR-OCTA into superficial, intermediate, and deep retinal plexuses. Two masked graders examined 3-layer PR-OCTA and combined angiograms for nonperfusion and abnormal capillaries. MAIN OUTCOMES AND MEASURES: Retinal nonperfusion and capillary abnormalities and the diagnostic accuracy of detecting DR. RESULTS: Twenty-nine eyes of 15 healthy individuals (mean [SD] age, 36.2 [13.4] years; 11 women) and 47 eyes of 29 patients with DR (mean [SD] age, 55.5 [11.9]; 10 women) underwent imaging. PR-OCTA revealed 3 distinct retinal plexuses in their known anatomical locations in all eyes. The intermediate and deep plexuses of healthy eyes revealed capillary networks of uniform density and caliber, whereas the superficial plexus revealed vessels in the familiar centripetal branching pattern. In eyes with DR, 3-layer PR-OCTA disclosed incongruent areas of nonperfusion and varied vessel caliber and density in the deeper plexuses. Masked grading of capillary nonperfusion on 3-layer PR-OCTA detected DR with 100% sensitivity (95% CI, 90.8%-100%) and 100% specificity (95% CI, 85.4%-100%). With unsegmented retinal angiograms, the sensitivity and specificity were 78.7% (95% CI, 63.9%-88.8%) and 100% (95% CI, 85.4%-100%), respectively (P = .002 for sensitivity). On 3-layer PR-OCTA, sensitivity was 72.2% (95% CI, 54.6%-85.2%) for severe nonproliferative DR and proliferative DR eyes with generalized nonperfusion in 2 or more individual plexuses, but on combined angiogram, sensitivity was 25.0% (95% CI, 12.7%-42.5%) for generalized nonperfusion (P < .001). PR-OCTA disclosed dilated vessels in the intermediate and deep plexuses in 23 eyes (100%) with proliferative DR, 13 eyes (100%) with severe nonproliferative DR, 8 eyes (73%) with mild to moderate nonproliferative DR, and 0 control eyes. CONCLUSIONS AND RELEVANCE: By presenting 3 retinal vascular plexuses distinctly, PR-OCTA reveals capillary abnormalities in deeper layers with clarity and may distinguish DR from healthy eyes and severe DR from mild DR with greater accuracy compared with conventional OCTA.
引用
- Hwang TS, Zhang M, Bhavsar K, et al. Visualization of 3 Distinct Retinal Plexuses by Projection-Resolved Optical Coherence Tomography Angiography in Diabetic Retinopathy. JAMA Ophthalmol. 2016. PMID: 27812696. doi:10.1001/jamaophthalmol.2016.4272
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。